Global gene expression analysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period (2024-2031). The ongoing advancement in genomic testing due to increased focus on the genome to treat chronic genetic disorders is a key factor driving the global market. For instance, in February 2024, NanoString Technologies, Inc. announced the commercial availability of the CosMx Human 6K Discovery Panel, the first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway.
Further, in January 2024, Thermo Fisher Scientific announced a next-generation Invitrogen TaqMan Cells-to-CT Express Kit, offering simplified, scalable workflows for gene expression analysis that produce less plastic waste. With improved chemistry, the Cells-to-CT Express Kit helps facilitate the preparation of cell lysates for reverse transcription (RT) real-time PCR (qPCR) in just five minutes.
Browse the full report description of “Gene Expression Analysis Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Microarray), by Product (Instruments, Reagents & Consumables, and Services), By End-User (Drug Discovery and Development, Diagnostic Laboratories, and Academic Research Centers) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/gene-expression-analysis-market
Furthermore, in June 2023, Sarepta Therapeutics, Inc. received the US FDA accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an adeno-associated virus-based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. This indication is approved under accelerated approval based on the expression of ELEVIDYS micro-dystrophin observed in patients treated with ELEVIDYS.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Technology
o By Product
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Quest Diagnostics Inc., Illumina, Inc., PerkinElmer Inc., Agilent Technologies Inc., and Promega Corp. among others.
Key questions addressed by the report
Global Gene Expression Analysis Market Report Segment
By Technology
By Product
By End-User
Global Gene Expression Analysis Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gene-expression-analysis-market